相关实验视频

Updated: Jul 6, 2026

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

全癌症分析确定了EIPR1作为肺腺癌的潜在预后和免疫生物标志物及其功能验证

Xin Zheng1, Xiao Zhang2, Jie Yu1

  • 1Department of Diagnostic Pathology, Shandong Second Medical University, Weifang 261053, China.

Gene
|March 28, 2025
PubMed
概括

在大多数癌症中,EARP和GARP复合相互作用蛋白1 (EIPR1) 过度表达,作为潜在的预后生物标志物. EIPR1影响瘤进展,可能是癌症预后和免疫治疗的目标.

关键词:
药物敏感性 药物敏感性在 EIPR1 中.免疫系统的透.肺部腺癌瘤是肺部腺癌.胰腺癌是一种癌症.预测 预后 预测 预测

更多相关视频

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

相关概念视频

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...